Antibody targeting of claudin-1 as a potential colorectal cancer therapy

Antibody targeting of claudin-1 as a potential colorectal cancer therapy

Abstract Background Metastatic colorectal cancer (mCRC) is one of the major causes of cancer-related death. Despite the substantial progress in mCRC management, it remains important to identify new therapeutic options and biological markers for personalized medicine. Here, we investigated the expres...

Full description

Bibliographic Details
Main Authors: S. Cherradi, A. Ayrolles-Torro, N. Vezzo-Vié, N. Gueguinou, V. Denis, E. Combes, F. Boissière, M. Busson, L. Canterel-Thouennon, C. Mollevi, M. Pugnière, F. Bibeau, M. Ychou, P. Martineau, C. Gongora, M. Del Rio
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Metastatic
Colorectal cancer
Claudin-1
Antibody
Targeted therapy
Online Access:http://link.springer.com/article/10.1186/s13046-017-0558-5

Internet

http://link.springer.com/article/10.1186/s13046-017-0558-5

Similar Items